[5] The most scientifically cautious interpretation is not that broad off-target inhibition has been proven, but that broader non-target effects cannot be excluded when experiments use high concentrations, long exposure windows, sensitive cell systems, or designs lacking orthogonal NNMT validation
Dalgard FJ, Gieler U, Tomas Aragones L, Lien L, Poot F, et al
Burke AC, Telford DE, Huff MW
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes
A: It is commonly used for dark spots, post-acne marks, sun spots, and uneven tone